Who Owns Spinraza?
Spinraza (nusinersen) is a spinal muscular atrophy therapy owned by Biogen Inc. (NASDAQ: BIIB). Approved in 2016 as the first SMA treatment, it is administered by intrathecal injection and remains a top Biogen revenue product.
Spinraza Timeline
GlobalOfficial Website
Who Owns Spinraza?
- Parent Company: Biogen Inc.
- Ownership Type: Product line
- Company Type: Publicly Traded
- Stock Ticker: NASDAQ: BIIB
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Spinraza | Biogen Inc. | Product line |
Where to Buy
Disclosure: We may earn commission from purchases
Spinraza on AmazonAdvertisement
History of Spinraza
- Founded: 2016
- Founders: Ionis Pharmaceuticals (licensed to Biogen)
Licensed from Ionis Pharmaceuticals, Spinraza became the first approved SMA therapy in December 2016, transforming treatment of the genetic disease before gene therapy competition arrived.
About Biogen Inc.
Is Biogen publicly traded?
Yes. It trades on NASDAQ under ticker BIIB.
What is Biogen's biggest drug?
Spinraza and Tysabri remain leading revenue products as the MS franchise declines; growth is led by Skyclarys, Zurzuvae, and Leqembi.
Who is the CEO of Biogen?
Christopher Viehbacher, president and chief executive officer.
Advertisement
Does Biogen make Leqembi?
Yes. Biogen co-develops and co-markets Leqembi (lecanemab) with Eisai.
- Founded: 1978
- Headquarters: Cambridge, Massachusetts, USA
- Company Type: Publicly Traded
- Stock: NASDAQ: BIIB
- Revenue: Approximately $9.7 billion (FY2025)
- Employees: Approximately 7,600
Where Is Spinraza Made / Based?
- Headquarters: Cambridge, Massachusetts, USA
Spinraza Categories & Tags
Brands Owned by Biogen Inc.
Healthcare PharmaceuticalsBiogen
Owned by Biogen Inc.
The biotechnology brand of Biogen Inc., focused on neurology therapeutics.
biotechneurologypharmaceuticals
Healthcare PharmaceuticalsLeqembi
Owned by Biogen Inc.
The Alzheimer's disease antibody therapy co-commercialized by Biogen and Eisai.
alzheimerslecanemableqembi
Healthcare PharmaceuticalsSkyclarys
Owned by Biogen Inc.
The Friedreich's ataxia therapy brand of Biogen, acquired through the 2023 Reata deal.
friedreichs-ataxiarare-diseaseskyclarys
Healthcare PharmaceuticalsTysabri
Owned by Biogen Inc.
The multiple sclerosis infusion therapy brand of Biogen, marketed for two decades.
multiple-sclerosisinfusiontysabri
Healthcare PharmaceuticalsZurzuvae
Owned by Biogen Inc.
The postpartum depression therapy brand of Biogen and Sage Therapeutics.
postpartum-depressionppdzurzuvae
Advertisement
Spinraza Ownership: Pros & Cons
Advantages
- +First-mover SMA brand
- +Long-term outcome data
Considerations
- -Gene therapy competition
- -Intrathecal administration burden
Frequently Asked Questions About Spinraza
Advertisement
Sources & Further Reading
- Spinraza official website
- Biogen Inc. company page - /companies/biogen
Competitors to Spinraza
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Biogen | USA | 2023 | Mass market | Global | All Genders |
Learn More About Competitors
Competitive Analysis
Market Positioning: Spinraza competes with 1 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Advertisement
Independent Alternatives to Spinraza
Looking for brands with different ownership structures? These similar brands are not owned by Biogen Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsAvaility
Owned by Availity
The largest real-time health information network in the US, owned by a consortium of major health insurers and Novo Holdings.
healthcare-technologyclearinghouseclaims-processing
Privately Owned
Availity is privately owned, unlike Spinraza which is under a publicly traded parent company.
Healthcare PharmaceuticalsBand-Aid
Owned by Kenvue
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
wound-careadhesive-bandagefirst-aid
Privately Owned
Band-Aid is privately owned, unlike Spinraza which is under a publicly traded parent company.
Healthcare PharmaceuticalsBenadryl
Owned by Kenvue
American brand of antihistamine medication used to treat allergies, itching, and cold symptoms, manufactured and marketed by Johnson & Johnson.
antihistamineallergy-reliefcold-medicine
Privately Owned
Benadryl is privately owned, unlike Spinraza which is under a publicly traded parent company.
Healthcare PharmaceuticalsBoots
Owned by Walgreens Boots Alliance
Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.
pharmacyhealth-beautyuk-retail
Privately Owned
Boots is privately owned, unlike Spinraza which is under a publicly traded parent company.
Healthcare PharmaceuticalsDuane Reade
Owned by Walgreens Boots Alliance
Duane Reade is a New York City drugstore chain owned by Walgreen Co. under Sycamore Partners, operating approximately 90 stores across the five boroughs.
pharmacydrugstorenew-york
Privately Owned
Duane Reade is privately owned, unlike Spinraza which is under a publicly traded parent company.
Healthcare PharmaceuticalsMD Clarity
Owned by MD Clarity
Seattle healthcare SaaS platform for patient cost estimates, payer contract management, and underpayment detection.
healthcare-technologyrevenue-cyclecontract-management
Privately Owned
MD Clarity is privately owned, unlike Spinraza which is under a publicly traded parent company.
Biogen Inc. Stock Information
Advertisement
Jobs at Biogen Inc.
Latest News About Spinraza
Advertisement
Related Articles About Spinraza
View more articles
News & Updates
Monthly IPO Roundup: November 2026 -- October's Biggest Listings
October 2026 IPOs: Jio Platforms set India's all-time record at $3.2B and surged 27%, GCash owner Mynt raised a Philippine-record P60.9B, Anthropic filed publicly for a possible mid-November debut, and U.S. listings were a biotech grab bag. Full recap.
Who Brands StaffNov 6, 2026
Ipo RoundupIpoStock Market
News & Updates
Monthly M&A Roundup: October 2026 Brand Ownership Changes
October 2026's biggest deals: Paramount Skydance closed its $110B Warner Bros. Discovery takeover, Salesforce signed Braze for $5.66B, Proofpoint bought Varonis for $6.3B, the Weston family agreed to buy Boots for $8.9B, and Viatris added Pacira for $1.65B. Full breakdown.
Who Brands StaffNov 6, 2026
M And A RoundupAcquisitionsNews
Rivalry
Duracell vs Energizer: The Battery Brand Rivalry
Duracell is Berkshire Hathaway-owned (25-30% US share). Energizer is publicly traded (NYSE: ENR) with Rayovac. Together they control ~85% of branded US batteries, but Amazon Basics has 27.1% online. Explore our database.
Who Brands StaffOct 23, 2026
DuracellEnergizerRivalry
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Brandrsv-vaccine
Abrysvo
Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.
Brand in Healthcare & Pharmaceuticals
vaccinesmaternal-immunization
Brandspecialty-pharmacy
Accredo
Specialty pharmacy founded in 1996 in Memphis, serving patients with complex and rare conditions as the specialty pharmacy of Evernorth within The Cigna Group.
Brand in Healthcare & Pharmaceuticals
rare-diseaseevernorth